Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vibha Sharma

Vibha Sharma is a senior reporter covering pharmaceutical and medtech regulatory developments across the globe. She joined Scrip Regulatory Affairs in September 2010 and has since then been at the center of deciding and writing news on important regulatory issues affecting the pharma and medtech sectors and explaining their implications for the industry.

Her fields of interest include the EU Pharmacovigilance legislation and the EU Paediatrics Regulation on which she has written several exclusive articles from various industry conferences. She has also commissioned some pieces of expert analysis on major developments in the pharma and medtech regulatory arenas.

Before joining Informa, she was principal correspondent with India's national newspaper Hindustan Times, where she reported on health and medical issues, besides several other topics. She has also worked with two other Indian national dailies, The Indian Express and The Asian Age.

Advertisement
Set Alert for Articles By Vibha Sharma

Latest From Vibha Sharma

Keep It Simple: EU Consults On Future Design Of EMA’s Fee System

Following a report that identified several shortcomings of the European Medicines Agency fee system, the European Commission has suggested various options to make it sustainable and future-proof.

Europe Regulation

IMDRF Consults On Specific Requirements For Recognizing CABs

Medical device regulators around the world have proposed new guidance for designating conformity assessment bodies because requirements in existing international standards are too generic.

International Guidance Documents

Pharma Wary Of Over-Flexible EU Plan For Electronic Product Information

The pharmaceutical industry is concerned that too much flexibility may result in a “fragmented and cost intensive implementation” of the EU electronic product information framework.

Europe Regulation

Canada’s Drug Pricing Reform Faces Legal Challenge

Canada’s R&D drug industry says it approached the court as a “necessary step,” given the significant impact of the pricing reforms.

Canada Pricing Debate

Ambiguous And Stifling: Pharma On ICH Bioanalytical Method Validation Guide

EU pharma is concerned that certain proposals in a new international guideline on bioanalytical method validation could be overinterpreted, increase burden on companies and stifle ‘scientific freedom.’

International Europe

Global Pharma Guidance Tracker – August 2019

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Guidance Documents International
See All
Advertisement
UsernamePublicRestriction

Register